DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2269135/markets-up-to-start-the-week-pltr-mchp-meet-earnings?cid=CS-ZC-FT-ahead_of_wall_street-2269135 May 06, 2024 - It's the third-straight up-day for both the S&P 500 and the Nasdaq, fourth straight for the blue-chip Dow. 0

https://www.zacks.com/stock/news/2270018/gxo-logistics-gxo-q1-earnings-meet-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270018 May 07, 2024 - GXO Logistics (GXO) delivered earnings and revenue surprises of 0% and 3.45%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.ocregister.com/2024/05/08/santa-margaritas-boys-and-girls-to-be-challenged-at-cif-state-swim-meet-this-weekend/ May 08, 2024 - Santa Margarita's girls will be without star Teagan O'Dell as they try to win their fifth state title in a row, while the boys will face tough competition from Loyola and Northwood. 0

https://www.zacks.com/stock/news/2270983/orasure-technologies-osur-q1-earnings-meet-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2270983 May 08, 2024 - OraSure (OSUR) delivered earnings and revenue surprises of 0% and 3.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.boston.com/news/health/2024/05/09/modernas-mrna-massachusetts-first-post-covid-shot/ May 09, 2024 -

The forthcoming RSV shot, expected to get US regulatory approval this month, is Moderna’s first chance to show the versatility of mRNA technology to more effectively treat and prevent a range of illnesses from the flu to cancer.

The post Moderna’s mRNA dreams meet reality with first post-Covid shot appeared first on Boston.com.

0

https://www.zacks.com/stock/news/2271696/wolverine-www-q1-earnings-meet-estimates-revenues-dip-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2271696 May 09, 2024 - Wolverine's (WWW) Q1 results reflect y/y declines in revenues and earnings. Nonetheless, the company is enhancing its core brands like Merrell and Saucony, and improving operational efficiencies. 0

https://www.zacks.com/stock/news/2272311/pharma-stock-roundup-pfe-dmd-study-patient-death-fda-panel-meet-for-lly-s-donanemab?cid=CS-ZC-FT-analyst_blog|stock_roundup-2272311 May 10, 2024 - Pfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's (LLY) donanemab is set to take place on Jun 10. 0

https://www.zacks.com/stock/news/2272810/bitdeer-technologies-group-btdr-q1-earnings-meet-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2272810 May 13, 2024 - BITDEER TEC GRP (BTDR) delivered earnings and revenue surprises of 0% and 0.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2272954/bristol-myers-bmy-fails-to-meet-goal-in-opdivo-nsclc-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2272954 May 13, 2024 - Bristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails to meet the primary endpoint of progression-free survival in unresectable stage III NSCLC. 0

https://seekingalpha.com/article/4692563-pty-looks-a-lot-more-interesting-after-the-last-fed-meeting?source=feed_tag_etf_portfolio_strategy May 14, 2024 - PTY has provided consistent income for investors despite its shares trading sideways. Check out why I continue to be bullish on the fund. 0